Serogroup W135 meningococcal disease, The Gambia, 2012.
Hossain, MJ
; Roca, A; Mackenzie, GA; Jasseh, M; Hossain, MI; Muhammad, S; Ahmed, M; Chidiebere, OD; Malick, N; Bilquees, S; +8 more...Ikumapayi, UN; Jeng, B; Njie, B; Cham, M; Kampmann, B; Corrah, T; Howie, S; D'Alessandro, U and
(2013)
Serogroup W135 meningococcal disease, The Gambia, 2012.
Emerging infectious diseases, 19 (9).
pp. 1507-1510.
ISSN 1080-6040
DOI: 10.3201/eid1909.130077
; Roca, A; Mackenzie, GA; Jasseh, M; Hossain, MI; Muhammad, S; Ahmed, M; Chidiebere, OD; Malick, N; Bilquees, S; +8 more...Ikumapayi, UN; Jeng, B; Njie, B; Cham, M; Kampmann, B; Corrah, T; Howie, S; D'Alessandro, U and
(2013)
Serogroup W135 meningococcal disease, The Gambia, 2012.
Emerging infectious diseases, 19 (9).
pp. 1507-1510.
ISSN 1080-6040
DOI: 10.3201/eid1909.130077
In 2012, an outbreak of Neisseria meningitidis serogroup W135 occurred in The Gambia. The attack rate was highest among young children. The associated risk factors were male sex, contact with meningitis patients, and difficult breathing. Enhanced surveillance facilitates early epidemic detection, and multiserogroup conjugate vaccine could reduce meningococcal epidemics in The Gambia.
-
picture_as_pdf - Serogroup W135 meningococcal disease, The Gambia, 2012.pdf
-
subject - Published Version
-
- Available under Creative Commons: Attribution 3.0
Downloads